ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,436.20
-0.10%
S&P ASX All Technology
3,964.00
0.35%
Brent Oil
71.98
0.00%
US Dollar vs AUD
1.53421
0.00%
Bitcoin
96,472.24
0.04%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Menlo Therapeutics Inc (MNLO)

  7. Menlo Therapeutics Inc (MNLO) News

MNLO

Menlo Therapeutics (MNLO)

Menlo Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MNLO
DateTimeSourceHeadlineSymbolCompany
03/06/202306:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNLOMenlo Therapeutics Inc
03/06/202306:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNLOMenlo Therapeutics Inc
12/05/202306:25Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MNLOMenlo Therapeutics Inc
12/05/202306:22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MNLOMenlo Therapeutics Inc
01/05/202322:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MNLOMenlo Therapeutics Inc
05/04/202307:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNLOMenlo Therapeutics Inc
05/04/202307:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNLOMenlo Therapeutics Inc
23/03/202307:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNLOMenlo Therapeutics Inc
15/03/202308:14Edgar (US Regulatory)Annual Report (10-k)NASDAQ:MNLOMenlo Therapeutics Inc
10/03/202308:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MNLOMenlo Therapeutics Inc
11/02/202309:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MNLOMenlo Therapeutics Inc
18/01/202309:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MNLOMenlo Therapeutics Inc
13/01/202309:14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MNLOMenlo Therapeutics Inc
05/01/202309:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNLOMenlo Therapeutics Inc
05/01/202309:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNLOMenlo Therapeutics Inc
05/01/202309:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNLOMenlo Therapeutics Inc
03/12/202208:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNLOMenlo Therapeutics Inc
26/11/202206:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:MNLOMenlo Therapeutics Inc
19/11/202209:01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:MNLOMenlo Therapeutics Inc
15/11/202208:51Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:MNLOMenlo Therapeutics Inc
15/11/202208:30Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MNLOMenlo Therapeutics Inc
11/11/202208:21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MNLOMenlo Therapeutics Inc
05/10/202208:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNLOMenlo Therapeutics Inc
13/08/202207:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNLOMenlo Therapeutics Inc
13/08/202207:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNLOMenlo Therapeutics Inc
13/08/202207:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNLOMenlo Therapeutics Inc
13/08/202206:26Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MNLOMenlo Therapeutics Inc
29/07/202206:31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:MNLOMenlo Therapeutics Inc
27/07/202223:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MNLOMenlo Therapeutics Inc
20/07/202207:01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:MNLOMenlo Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MNLO

Your Recent History

ASX
CSL
CSL
ASX
ORG
Origin Energy
ASX
QBE
QBE Insurance
NYSE
XOM
Exxon Mobil
ASX
XMM
S&P ASX 300 Metals and M...
ASX
ANZ
Australia And New Zealan...
ASX
WOW
Woolworths
ASX
XAO
Australian SE All Ordina...
NASDAQ
MSFT
Microsoft
NASDAQ
GOOGL
Alphabet
ASX
FMG
Fortescue
FX
AUDCAD
AUD vs CAD
NYSE
MRK
Merck
ASX
MQG
Macquarie
NYSE
VZ
Verizon Communications
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for ASX Level 1 & 2

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $1958.40 only $783.36